Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paranjape

Showing results (681-690 of 748) with videos related to

Pageof 75
Sort By:
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Frontiers in Bioengineering and Biotechnology|August 21, 2018
Bt Eggplant Project in Bangladesh: History, Present Status, and Future DirectionA M Shelton, M J Hossain, V Paranjape, et al.
Molecular Cancer Therapeutics|March 13, 2023
Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast CancerImran Khan, Brunilde Gril, Anurag N Paranjape, et al.
The Lancet. Oncology|March 26, 2011
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysisTrupti Paranjape, Helen Heneghan, Robert Lindner, et al.
Virology|January 27, 2009
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from IndiaSmita S Kulkarni, Alan Lapedes, Haili Tang, et al.
Autonomic Neuroscience : Basic & Clinical|July 2, 2023
Adrenal gland response to adrenocorticotropic hormone is intact in patients with postural orthostatic tachycardia syndromeJill K H Laurin, Oyebimbola A Oyewunmi, Emily M Garland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2014
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinomaC H Chung, J W Lee, R J Slebos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2017
TGF-β1 Suppresses IL-33-Induced Mast Cell FunctionVictor S Ndaw, Daniel Abebayehu, Andrew J Spence, et al.
The Journal of Biological Chemistry|December 12, 2025
Small molecule intervention of actin-binding protein profilin1 reduces tumor angiogenesis in renal cell carcinomaDavid Gau, Pooja Chawla, Kexin Xu, et al.
The Journal of Infectious Diseases|January 7, 2011
Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virusAmita Gupta, Ramesh Bhosale, Arti Kinikar, et al.
Pageof 75

Showing results (681-690 of 748) with videos related to

Sort By:
Pageof 75
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Frontiers in Bioengineering and Biotechnology|August 21, 2018
Bt Eggplant Project in Bangladesh: History, Present Status, and Future DirectionA M Shelton, M J Hossain, V Paranjape, et al.
Molecular Cancer Therapeutics|March 13, 2023
Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast CancerImran Khan, Brunilde Gril, Anurag N Paranjape, et al.
The Lancet. Oncology|March 26, 2011
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysisTrupti Paranjape, Helen Heneghan, Robert Lindner, et al.
Virology|January 27, 2009
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from IndiaSmita S Kulkarni, Alan Lapedes, Haili Tang, et al.
Autonomic Neuroscience : Basic & Clinical|July 2, 2023
Adrenal gland response to adrenocorticotropic hormone is intact in patients with postural orthostatic tachycardia syndromeJill K H Laurin, Oyebimbola A Oyewunmi, Emily M Garland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2014
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinomaC H Chung, J W Lee, R J Slebos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2017
TGF-β1 Suppresses IL-33-Induced Mast Cell FunctionVictor S Ndaw, Daniel Abebayehu, Andrew J Spence, et al.
The Journal of Biological Chemistry|December 12, 2025
Small molecule intervention of actin-binding protein profilin1 reduces tumor angiogenesis in renal cell carcinomaDavid Gau, Pooja Chawla, Kexin Xu, et al.
The Journal of Infectious Diseases|January 7, 2011
Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virusAmita Gupta, Ramesh Bhosale, Arti Kinikar, et al.
Pageof 75